Loading...
NPI 1326498593 · Bettendorf, IA · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Richard Yemm is a ophthalmology physician provider located in Bettendorf, Iowa. This profile covers 23 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Richard Yemm |
| Address | 777 Tanglefoot Ln |
| City | Bettendorf |
| State | IA |
| ZIP | 52722 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | June 17, 2016 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.4M |
| Medicaid | $6.1K |
Practice revenue is overwhelmingly Medicare-driven: the provider reports $2.4M in total Medicare revenue versus only $6.1K in total Medicaid revenue, making the operation effectively a Medicare-centric practice with only trace Medicaid billing on file. The Medicaid billing that does exist is concentrated entirely in 67028 (100.0% of Medicaid revenue), so Medicaid is not a meaningful revenue source for scale or strategy analysis.
Revenue concentration on Medicare is high: the top three Medicare codes by revenue (J0178, J2777, 66984) account for 76.8% of this provider's total Medicare revenue, indicating a narrow set of services drives most billings. Within that mix, J0178 alone represents 44.4% of Medicare revenue and J2777 25.6%, so anti-VEGF intravitreal injections dominate the financial profile.
Service-line implication — retina-focused medical practice with cataract surgery activity: heavy billing for intravitreal injection codes (J0178, J2777, Q5124, J2778, J9035) points to a strong medical-retina focus delivering frequent anti-VEGF treatments, while 66984 (cataract extraction with IOL insertion) and related codes (92136 biometry, 66821 YAG capsulotomy) show concurrent surgical cataract services. Diagnostic imaging codes such as 92134 (OCT of retina) and 92133 (OCT of optic nerve) support a practice model that combines high-volume retinal therapeutics with in-office imaging and perioperative cataract care.
Competitive standing on top Medicare codes is modest-to-moderate nationally: J0178 ranks #788 of 3204 providers nationally (75th percentile) and J2777 ranks #488 of 2039 providers nationally (76th percentile), both described in the source as typical, unremarkable volume for those codes — this suggests the provider treats a meaningful but not dominant share of anti-VEGF cases relative to national peers. The cataract surgery code 66984 sits at #3297 of 15965 providers (79th percentile), indicating surgical volume is similarly in the higher-but-typical range rather than an outlier.
Medicaid competitive position is weak in-state: the single Medicaid-billed procedure 67028 accounts for 100.0% of the provider's Medicaid revenue but ranks #13 of 15 providers in-state (14th percentile) and is labeled typical, unremarkable volume, showing the provider is a low-volume Medicaid performer for intravitreal injections within Iowa. Given the tiny absolute Medicaid revenue ($6.1K), the provider is effectively not competing for Medicaid retinal procedure volume.
Profile tenure and stability: the NPI was enumerated on 2016-06-17 (~10 years ago), indicating an established practice presence long enough to build the reported injection and cataract caseloads. The combination of durable anti-VEGF billing and ongoing surgical codes suggests a stable mixed medical-surgical ophthalmology practice rather than a newly entered or transient billing pattern.
Ancillary and diagnostic services show concentration in higher percentiles but are characterized as typical: imaging code 92134 (1.1K claims, 93rd percentile) and device/implant code 68841 (372 claims, 92nd percentile) rank highly versus national peers, which aligns with a practice that performs substantial in-office diagnostics and device procedures to support retina and ocular surface care; however, the dataset labels these as typical, unremarkable volumes for those codes. This pattern reinforces a full-service ophthalmology workflow where diagnostics and office procedures back procedural revenue rather than indicating atypical billing behavior.
No strong statistical outliers flagged in the dataset: most listed Medicare and Medicaid codes are described in the source as having "typical, unremarkable volume for this code," so while the provider concentrates revenue in anti-VEGF injections, their per-code volumes fall within the expected national/state distributions rather than being described as extreme or notably anomalous. For payer-strategy purposes, the provider should be treated as a medically retina-focused ophthalmologist with standard-to-high but not exceptional procedural throughput relative to peers.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
23 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,550 | $690 | $1.1M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 21,240 | $30 | $616K |
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 410 | $400 | $165.6K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,590 | $90 | $141.9K |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 790 | $170 | $130.3K |
| J2778 | Injection, ranibizumab, 0.1 mg | 650 | $180 | $119.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 410 | $90 | $36.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,120 | $30 | $31.4K |
| J9035 | Injection, bevacizumab, 10 mg | 510 | $50 | $27.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 260 | $60 | $15K |
Showing 1–10 of 23
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
23 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J2777 | 16 | 20 | 43,140 | $30 | $1.7M |
| J0178 | 9 | 40 | 640 | $690 | $760.2K |
| J2778 | 12 | 20 | 780 | $180 | $259.9K |
| Q5124 | 2 | 10 | 740 | $170 | $130.5K |
| 67028 | 14 | 60 | 420 | $80 | $80.6K |
| 66984 | 27 | 340 | 50 | $340 | $50.4K |
| 92014 | 393 | 500 | 200 | $70 | $19.8K |
| 99214 | 672 | 4,690 | 100 | $70 | $14.4K |
| 66821 | 50 | 130 | 40 | $210 | $14.4K |
| J9035 | 1 | 10 | 200 | $50 | $14.2K |
Showing 1–10 of 23
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 30 | $200 | $6.1K |
How this provider's Medicaid billing volume and revenue compare to other Iowa providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Iowa median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 13 | 20 | 460 | $140 | $410.5K |
Other providers in the same ZIP code as Richard Yemm, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.